Literature DB >> 12660795

Roles of dopamine signaling in nicotine addiction.

J A Dani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12660795     DOI： 10.1038/sj.mp.4001284

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  25 in total

1.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration.

Authors:  Daniele Lecca; Fabio Cacciapaglia; Valentina Valentini; Janne Gronli; Saturnino Spiga; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

2.  Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.

Authors:  Rubing Zhao-Shea; Liwang Liu; Lindsey G Soll; Ma Reina Improgo; Erin E Meyers; J Michael McIntosh; Sharon R Grady; Michael J Marks; Paul D Gardner; Andrew R Tapper
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference.

Authors:  Gofarana Wilar; Yasuharu Shinoda; Toshikuni Sasaoka; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2019-05-25       Impact factor: 5.590

Review 4.  Pharmacogenetics of nicotine addiction: role of dopamine.

Authors:  Aryeh I Herman; Elise E DeVito; Kevin P Jensen; Mehmet Sofuoglu
Journal:  Pharmacogenomics       Date:  2014-02       Impact factor: 2.533

5.  Cholinergic axons in the rat ventral tegmental area synapse preferentially onto mesoaccumbens dopamine neurons.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Comp Neurol       Date:  2006-02-20       Impact factor: 3.215

6.  Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Authors:  Jon O Ebbert; Kirk D Wyatt; J Taylor Hays; Eric W Klee; Richard D Hurt
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

7.  Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.

Authors:  Matthew I Palmatier; Melissa E Levin; Kara L Mays; Eric C Donny; Anthony R Caggiula; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2009-09-17       Impact factor: 4.530

8.  Local perfusion of nicotine differentially modulates somatodendritic dopamine release in the rat ventral tegmental area after nicotine preexposure.

Authors:  S Rahman; J Zhang; W A Corrigall
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 9.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

10.  Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Authors:  Linda P Dwoskin; Marharyta Pivavarchyk; B Matthew Joyce; Nichole M Neugebauer; Guangrong Zheng; Zhenfa Zhang; Michael T Bardo; Peter A Crooks
Journal:  Nebr Symp Motiv       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.